Immunoglobulin Allotypes in Hepatitis C Virus Infection
丙型肝炎病毒感染中的免疫球蛋白同种异型
基本信息
- 批准号:7367031
- 负责人:
- 金额:$ 18.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-03-01 至 2010-02-28
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAffectAffinityAfrican AmericanAntibodiesAntibody FormationBindingBiologicalCase-Control StudiesCaucasiansCaucasoid RaceClinicalDNA SequenceDetectionEnzyme-Linked Immunosorbent AssayEpitopesEthnic groupExperimental ModelsFrequenciesGenesGeneticGenotypeHaplotypesHealthHemagglutinationHepatitis CHepatitis C virusImmune responseImmunoglobulin AllotypesImmunoglobulin GImmunoglobulinsImmunologic SurveillanceIndividualInfectionIntegration Host FactorsInterferonsInvestigationLightMeasuresMethodsMolecular MimicryMonitorOutcomePersonsPhenotypePlayPopulationPopulation StudyPropertyRaceReportingRiskRoleSamplingSpecificitySurface Plasmon ResonanceSystemT-LymphocyteTestingThinkingVariantViralViral AntigensVirusbasecomparativecytotoxicitydesignreceptorreceptor bindingresponsesoundvirus pathogenesis
项目摘要
Hepatitis C virus (HCV) is a major health problem, affecting over 170 million people worldwide. Of persons
acutely infected with HCV, about 15% spontaneously clear the virus. Because of limitations in experimental
models and the infrequent recognition of natural acute infection, the mechanisms of viral clearance are
poorly understood. There are clinical and epidemiologic clues that suggest host factors are critical. Among
the factors influencing the outcome of HCV infection, the host genetic factors are thought to play a
predominant role. Immunoglobulin (Ig) GM and KM allotypes¿hereditary antigenic determinants of IgG
heavy chains and k-type light chains, respectively¿are associated with viral immunological properties, and
thus are ideal candidate genetic systems for investigations to identify risk-conferring factors in HCV
pathogenesis. We hypothesized that GM and KM allotypes may contribute to the outcome of HCV infection
through their possible influence on allotype-restricted antibody responses to the viral antigens. Additionally,
they may influence antibody dependent T cell cytotoxicity to HCV by their differential interaction with
Fcgamma receptors (FcgammaR). GM and KM allotypes could also modulate the strategies¿Ig molecular
mimicry and FcgammaR-like activity¿employed by this virus to evade host immune surveillance. To test
our hypothesis, a case control study has been designed with the following specific aims: (1) to further
establish the magnitude of association between the outcome of HCV infection and Ig GM and KM allotypes
in African Americans; (2) to determine if GM and KM allotypes are associated with the outcome of HCV
infection in Caucasians; (3) to measure the specificity and titer of the humoral immune responses to HCV
antigens (core, E1,E2,NS3,NS4,NS5) and determine if the production of these antibodies is influenced by
GM and KM allotypes; (4) to determine if HCV-encoded FcgammaR binds differentially with IgG molecules
carrying different GM allotypes. GM and KM allotyping will be done by hemagglutination-inhibition, direct
DNA sequencing, and PCR-RFLP methods. IgG antibodies to HCV antigens will be measured by an ELISA.
Binding and comparative affinities of IgG molecules of different GM allotypes to HCV-FcgammaR will be
monitored by surface plasmon resonance detection. Results of this investigation will advance our
understanding of the role of host genetic factors in clearance and persistence of hepatitis C virus infection.
丙型肝炎病毒 (HCV) 是一个主要的健康问题,影响着全世界超过 1.7 亿人。人数
急性感染HCV时,约15%会自发清除病毒。由于实验的限制
模型和自然急性感染的罕见认识,病毒清除的机制是
不太了解。临床和流行病学线索表明宿主因素至关重要。之中
影响HCV感染结果的因素中,宿主遗传因素被认为发挥着重要作用
占主导地位。免疫球蛋白 (Ig) GM 和 KM 同种异型——IgG 的遗传性抗原决定簇
重链和 k 型轻链分别与病毒免疫特性相关,并且
因此,这是用于研究以确定 HCV 风险因素的理想候选遗传系统
发病。我们假设 GM 和 KM 同种异型可能有助于 HCV 感染的结果
通过它们可能影响同种异型限制性抗体对病毒抗原的反应。此外,
它们可能通过与 HCV 的不同相互作用来影响抗体依赖性 T 细胞对 HCV 的细胞毒性。
Fcgamma 受体 (FcgammaR)。 GM 和 KM 同种异型也可以调节策略——Ig 分子
该病毒利用拟态和 FcgammaR 样活性来逃避宿主免疫监视。测试
我们的假设是,病例对照研究的设计目的如下:(1)进一步
确定 HCV 感染结果与 Ig GM 和 KM 同种异型之间的关联程度
在非裔美国人中; (2) 确定GM和KM同种异型是否与HCV结果相关
白种人感染; (3)测定HCV体液免疫反应的特异性和效价
抗原(核心、E1、E2、NS3、NS4、NS5)并确定这些抗体的产生是否受到以下因素的影响
GM 和 KM 同种异型; (4) 确定HCV编码的FcgammaR是否与IgG分子有差异结合
携带不同的转基因同种异型。 GM和KM同种异型分型将通过血凝抑制、直接进行
DNA 测序和 PCR-RFLP 方法。 HCV 抗原的 IgG 抗体将通过 ELISA 进行测量。
不同GM同种异型的IgG分子与HCV-FcgammaR的结合和比较亲和力将是
通过表面等离子体共振检测进行监测。这项调查的结果将推动我们
了解宿主遗传因素在丙型肝炎病毒感染清除和持续存在中的作用。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fc gamma receptor-like hepatitis C virus core protein binds differentially to IgG of discordant Fc (GM) genotypes.
Fc γ 受体样丙型肝炎病毒核心蛋白与不一致 Fc (GM) 基因型的 IgG 存在差异性结合。
- DOI:10.1016/j.molimm.2007.03.022
- 发表时间:2007
- 期刊:
- 影响因子:3.6
- 作者:Namboodiri,AryanM;Budkowska,Agata;Nietert,PaulJ;Pandey,JanardanP
- 通讯作者:Pandey,JanardanP
Interactive effects of immunoglobulin gamma and human leucocyte antigen genotypes on clearance and persistence of infection with hepatitis C virus.
免疫球蛋白γ和人类白细胞抗原基因型对丙型肝炎病毒感染的清除和持续性的相互作用。
- DOI:10.1111/j.1365-2249.2007.03519.x
- 发表时间:2007
- 期刊:
- 影响因子:4.6
- 作者:Pandey,JP;Montes-Cano,MA;Aguilar-Reina,J;Gonzalez-Escribano,MF
- 通讯作者:Gonzalez-Escribano,MF
Hepatitis C virus core protein discriminates between the two IgG2 allotypes.
丙型肝炎病毒核心蛋白可区分两种 IgG2 同种异型。
- DOI:10.1089/vim.2008.0008
- 发表时间:2008
- 期刊:
- 影响因子:2.2
- 作者:Namboodiri,AryanM;Nietert,PaulJ;Pandey,JanardanP
- 通讯作者:Pandey,JanardanP
Immunoglobulin GM and KM allotypes and antibody responses to Epstein-Barr virus antigens.
免疫球蛋白 GM 和 KM 同种异型以及对 Epstein-Barr 病毒抗原的抗体反应。
- DOI:10.1086/605019
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:Pandey,JanardanP
- 通讯作者:Pandey,JanardanP
Genetic variation at immunoglobulin kappa locus is associated with hepatitis C-treatment-induced viral clearance in African Americans.
免疫球蛋白 kappa 位点的遗传变异与非裔美国人丙型肝炎治疗诱导的病毒清除有关。
- DOI:10.1016/j.humimm.2011.03.026
- 发表时间:2011
- 期刊:
- 影响因子:2.7
- 作者:Pandey,JanardanP;Kistner-Griffin,Emily
- 通讯作者:Kistner-Griffin,Emily
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JANARDAN P PANDEY其他文献
JANARDAN P PANDEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JANARDAN P PANDEY', 18)}}的其他基金
Immunoglobulin Genes and Immunity to HSV1 in Alzheimer's Disease
阿尔茨海默病中的免疫球蛋白基因和 HSV1 免疫
- 批准号:
10576613 - 财政年份:2023
- 资助金额:
$ 18.69万 - 项目类别:
IGHG Genes (GM Allotypes) and Anti-CMV (UL70) Antibody Responses as Prognostic Markers for Chronic Graft-Versus-Host-Disease
IGHG 基因(GM 同种型)和抗 CMV (UL70) 抗体反应作为慢性移植物抗宿主病的预后标志物
- 批准号:
10624498 - 财政年份:2023
- 资助金额:
$ 18.69万 - 项目类别:
FCGRIIIA and IGHG (GM) Genotypes and Immunity to HSV1 in Herpes Stromal Keratitis
疱疹性基质性角膜炎中的 FCGRIIIA 和 IGHG (GM) 基因型以及对 HSV1 的免疫
- 批准号:
10675575 - 财政年份:2022
- 资助金额:
$ 18.69万 - 项目类别:
FCGRIIIA and IGHG (GM) Genotypes and Immunity to HSV1 in Herpes Stromal Keratitis
疱疹性基质性角膜炎中的 FCGRIIIA 和 IGHG (GM) 基因型以及对 HSV1 的免疫
- 批准号:
10507311 - 财政年份:2022
- 资助金额:
$ 18.69万 - 项目类别:
Immunoglobulin GM (γ marker) Allotypes and Immunity to HSV1 in Alzheimer’s Disease
阿尔茨海默病中免疫球蛋白 GM(γ 标记)同种异型和对 HSV1 的免疫
- 批准号:
10464940 - 财政年份:2021
- 资助金额:
$ 18.69万 - 项目类别:
Genetic Markers of IgG and Cytomegalovirus Immunoevasion in Alzheimer Disease
阿尔茨海默病中 IgG 和巨细胞病毒免疫逃避的遗传标记
- 批准号:
9386264 - 财政年份:2017
- 资助金额:
$ 18.69万 - 项目类别:
Genetic Modifiers of Immune Evasion by Cytomegalovirus in Glioblastoma
胶质母细胞瘤中巨细胞病毒免疫逃避的基因修饰
- 批准号:
8465930 - 财政年份:2012
- 资助金额:
$ 18.69万 - 项目类别:
Genetic Modifiers of Immune Evasion by Cytomegalovirus in Glioblastoma
胶质母细胞瘤中巨细胞病毒免疫逃避的基因修饰
- 批准号:
8374071 - 财政年份:2012
- 资助金额:
$ 18.69万 - 项目类别:
Immunoglobulin Allotypes in Hepatitis C Virus Infection
丙型肝炎病毒感染中的免疫球蛋白同种异型
- 批准号:
7029163 - 财政年份:2006
- 资助金额:
$ 18.69万 - 项目类别:
Immunoglobulin Allotypes in Hepatitis C Virus Infection
丙型肝炎病毒感染中的免疫球蛋白同种异型
- 批准号:
7188051 - 财政年份:2006
- 资助金额:
$ 18.69万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 18.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 18.69万 - 项目类别:
Operating Grants